Blood Collection Tubes Market by Tube Type (Citrate Tubes, EDTA Tubes, Glucose Tubes), Material (Glass Tubes, Plastic Tubes), Application, End User - Global Forecast 2025-2032
Description
The Blood Collection Tubes Market was valued at USD 4.18 billion in 2024 and is projected to grow to USD 4.46 billion in 2025, with a CAGR of 7.08%, reaching USD 7.23 billion by 2032.
Establishing the Critical Context for Blood Collection Tube Solutions Amid Evolving Diagnostic Needs and Healthcare Priorities Worldwide
The global healthcare ecosystem increasingly relies on precise and reliable blood collection processes to drive diagnostic accuracy and patient outcomes. As medical professionals expand the range of tests required for personalized medicine, the devices used to acquire and preserve samples have become indispensable. Blood collection tubes serve as the critical interface between patient and laboratory, preserving specimen integrity from the point of draw through analysis.
In recent years, the industry has witnessed growing demand for innovations that streamline phlebotomy workflows while maintaining stringent quality standards. Regulatory bodies continue to refine safety protocols for handling infectious and sensitive specimens, raising the bar for manufacturers. Consequently, tube suppliers are investing in advanced additive formulations, enhanced barrier coatings, and digital integration features that support chain-of-custody traceability and cold-chain management.
Together, these developments underscore a broader trend toward operational efficiency and clinical confidence. With this context in mind, the following analysis explores the transformative shifts, geopolitical considerations, and strategic imperatives shaping the future of blood collection tube solutions.
Uncovering Pivotal Technological and Process Innovations Reshaping the Blood Collection Tube Sector in Response to Emerging Healthcare Demands
Technological advancements are propelling the blood collection tube sector into a new era of performance and safety. Automated cap pierce systems, novel clot activators, and specialized separator gels have accelerated sample processing while reducing pre-analytical errors. At the same time, a growing emphasis on point-of-care testing has driven demand for tubes compatible with portable analyzers and rapid turnaround workflows.
Moreover, material science innovations have introduced lightweight plastic tubes with enhanced rigidity and glass tubes with improved break resistance. These shifts reflect industry efforts to reconcile concerns around environmental impact, supply chain stability, and user ergonomics. Collectively, such innovations are reshaping procurement criteria, prompting laboratories and hospitals to seek solutions that balance cost, performance, and sustainability.
Assessing the Far-Reaching Consequences of Recent United States Tariff Measures on Blood Collection Tube Import Dynamics and Supply Chain Resilience
The introduction of new tariff measures by the United States has led to a reexamination of import dependencies for blood collection tubes. Suppliers that historically relied on cross-border sourcing are now grappling with increased landed costs and extended lead times. As a result, managers are assessing the feasibility of nearshoring production or securing long-term contracts to hedge against further tariff escalations.
Consequently, strategic buyers are prioritizing supply chain resilience by diversifying their vendor base and negotiating more flexible terms. In certain cases, organizations are collaborating with domestic manufacturers to tailor product specifications and qualify secondary packaging. Looking ahead, maintaining a balanced procurement strategy that aligns cost control with uninterrupted availability will remain paramount in mitigating the ongoing impacts of tariff-related disruptions.
Delving into the Multifaceted Segmentation of Blood Collection Tubes Across Types, Materials, Applications, and End Users to Reveal Strategic Opportunities
A comprehensive analysis of blood collection tube demand reveals critical distinctions across multiple axes. When examining tube types, it becomes clear that the choice between citrate tubes for coagulation studies and EDTA tubes for hematology assessments influences procurement patterns. Similarly, glucose tubes, heparin tubes, plasma separation tubes, and serum separation tubes each address specific diagnostic requirements, shaping inventory management decisions in clinical settings.
Equally instructive is the comparison of tube materials. Glass tubes continue to be favored for applications demanding superior clarity and chemical resistance, whereas plastic tubes offer enhanced safety and reduced breakage risk. Procurement teams must weigh these trade-offs in light of storage, transportation, and disposal protocols. In parallel, varied applications-from blood banking through clinical diagnostics to forensic analysis, molecular diagnostics, and research and development-drive differentiated volume requirements and tube specifications.
End user profiles further refine market segmentation insights. Blood banks demand high throughput and standardized lot control. Diagnostic laboratories seek compatibility with automated handling systems. Home care settings require easy-to-use formats and leak-proof designs. Hospitals emphasize clinician safety and rapid turnaround, while research institutions prioritize customization and reagent integration. Recognizing the interplay of these segments is essential for aligning product portfolios with emerging customer expectations.
Examining Regional Dynamics and Growth Drivers for Blood Collection Tubes Across Americas, Europe Middle East & Africa, and Asia-Pacific to Guide Strategy
Regional market characteristics underscore the diversity of demand drivers and regulatory landscapes. In the Americas, well-established healthcare infrastructure and strong private-public partnerships foster continuous investments in diagnostic capabilities. Laboratories and hospitals in North and South America often spearhead early adoption of next-generation tube technologies due to competitive pressures and rigorous accreditation requirements.
Meanwhile, Europe, the Middle East & Africa exhibit a mosaic of regulatory frameworks and economic conditions. The European Union’s in vitro diagnostic regulations harmonize product approvals across member states, creating a unified standard for tube performance. In contrast, markets in the Middle East and Africa are catalyzing growth through public health initiatives and modernization of laboratory networks.
In Asia-Pacific, rapid urbanization, expanding healthcare coverage, and rising disposable incomes are fueling elevated testing volumes. Emerging economies are investing in domestic manufacturing capabilities to reduce import reliance. Across all regions, supply chain optimization and localized production remain critical strategies to ensure consistent access to high-quality blood collection tubes.
Highlighting Competitive Profiles and Strategic Initiatives of Leading Blood Collection Tube Manufacturers to Illustrate Market Leadership and Innovation Trends
Leading manufacturers have adopted distinct strategies to solidify their positions in the blood collection tube sector. Some have prioritized product diversification, unveiling proprietary additive formulations that enhance sample stability and broadening their portfolios to cover clinical, molecular, and forensic applications. Others have pursued targeted partnerships with diagnostic instrument providers, ensuring seamless integration and co-branding opportunities.
In addition, vertical integration has emerged as a key competitive lever. By controlling raw material sourcing or investing in automated filling and labeling lines, certain firms have achieved cost efficiencies and accelerated time to market. Geographic expansion remains a focal point, with several companies establishing distribution centers in high-growth regions to reduce lead times and adapt to local regulatory requirements.
Collectively, these strategic initiatives illustrate how market leaders are balancing innovation, operational excellence, and customer engagement to meet evolving clinical demands while reinforcing their global footprint.
Offering Clear Recommendations for Industry Leaders to Navigate Regulatory, Technological, and Supply Chain Challenges in Blood Collection
To navigate the complexities of this evolving landscape, industry leaders should first invest in research and development that anticipates emerging diagnostic modalities. By collaborating with clinical partners to validate novel tube chemistries and coatings, organizations can position themselves at the forefront of precision medicine workflows.
Furthermore, leaders must enhance supply chain agility by diversifying manufacturing footprints and cultivating relationships with multiple raw material suppliers. This approach not only buffers against tariff-driven cost volatility but also supports regional compliance and rapid delivery to end users. In addition, embedding digital tracking solutions-from barcode serialization to cold-chain monitoring sensors-will bolster chain-of-custody assurances and strengthen regulatory alignment.
Finally, forging strategic alliances with diagnostic instrument manufacturers, healthcare providers, and regulatory consultants can expedite product approvals and drive cross-functional innovation. By adopting these proactive measures, companies will be well-equipped to capitalize on new market opportunities and sustain competitive advantage.
Detailing the Rigorous Research Methodology Used to Explore Blood Collection Tube Market Dynamics Through Data Collection, Validation, and Analytical Techniques
The analysis underpinning this report combined rigorous primary and secondary research methodologies. First, interviews were conducted with laboratory directors, procurement specialists, and product development executives to capture firsthand perspectives on operational challenges and unmet needs. These qualitative insights were triangulated with data drawn from regulatory filings, industry white papers, and internal company disclosures.
Subsequently, a structured validation process was implemented. Cross-referencing supplier catalogs and certification records ensured the accuracy of technical specifications and compliance statuses. Analytical frameworks, including SWOT analysis and value chain mapping, provided a systematic basis for evaluating competitive positioning and innovation trajectories. Finally, scenario modeling was employed to assess the potential impacts of tariff changes and regional policy shifts, yielding a robust foundation for strategic recommendations.
Synthesizing Key Insights and Considerations to Provide a Concluding Perspective on the Future Trajectory of Blood Collection Tubes in Healthcare
Throughout this executive summary, key themes have emerged: the critical role of material innovations, the impact of geopolitical factors on supply chain resilience, and the value of segmentation insights across types, applications, and end users. Regional analyses further highlighted the necessity of aligning manufacturing footprints with local regulatory environments and healthcare infrastructure.
By synthesizing the competitive moves of leading manufacturers and outlining actionable recommendations for research investment, supply chain diversification, and digital traceability, this report offers a comprehensive perspective on the forces shaping the blood collection tube sector. As diagnostic workflows evolve and patient-centric care continues to expand, stakeholders must remain vigilant and adaptive to sustain growth and ensure clinical excellence. These insights will serve as a roadmap for organizations seeking to strengthen their market position and deliver reliable, innovative solutions.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
Tube Type
Citrate Tubes
EDTA Tubes
Glucose Tubes
Heparin Tubes
Plasma Separation Tubes (PST)
Serum Separation Tubes (SST)
Material
Glass Tubes
Plastic Tubes
Application
Blood Banking
Clinical Diagnostics
Forensic
Molecular Diagnostics
Research & Development
End User
Blood Banks
Diagnostic Laboratories
Home Care Settings
Hospitals
Research Institutions
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
Americas
North America
United States
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Colombia
Peru
Europe, Middle East & Africa
Europe
United Kingdom
Germany
France
Russia
Italy
Spain
Netherlands
Sweden
Poland
Switzerland
Middle East
United Arab Emirates
Saudi Arabia
Qatar
Turkey
Israel
Africa
South Africa
Nigeria
Egypt
Kenya
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
Thailand
Malaysia
Singapore
Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
Abbott Laboratories
AdvaCare Pharma
Becton, Dickinson & Company
Biosigma S.p.A.
Bio‐Rad Laboratories, Inc.
Cardinal Health, Inc.
CML BIOTECH LIMITED
Convergent Technologies GmbH
Corning Incorporated
FL Medical S.R.L.
Greiner Bio One International Gmbh
Haemonetics Corporation
Labtech S.r.l.
Medline Industries, Inc.
Medtronic plc
Merck KGaA.
Micsafe Medical Group
Nanjing Vazyme Medical Technology Co., Ltd.
Nipro Medical Corporation
QIAGEN N.V.
Radiometer Medical ApS
SARSTEDT AG & Co. KG
Simport, Inc.
Terumo Corporation
Thermo Fisher Scientific
Please Note: PDF & Excel + Online Access - 1 Year
Establishing the Critical Context for Blood Collection Tube Solutions Amid Evolving Diagnostic Needs and Healthcare Priorities Worldwide
The global healthcare ecosystem increasingly relies on precise and reliable blood collection processes to drive diagnostic accuracy and patient outcomes. As medical professionals expand the range of tests required for personalized medicine, the devices used to acquire and preserve samples have become indispensable. Blood collection tubes serve as the critical interface between patient and laboratory, preserving specimen integrity from the point of draw through analysis.
In recent years, the industry has witnessed growing demand for innovations that streamline phlebotomy workflows while maintaining stringent quality standards. Regulatory bodies continue to refine safety protocols for handling infectious and sensitive specimens, raising the bar for manufacturers. Consequently, tube suppliers are investing in advanced additive formulations, enhanced barrier coatings, and digital integration features that support chain-of-custody traceability and cold-chain management.
Together, these developments underscore a broader trend toward operational efficiency and clinical confidence. With this context in mind, the following analysis explores the transformative shifts, geopolitical considerations, and strategic imperatives shaping the future of blood collection tube solutions.
Uncovering Pivotal Technological and Process Innovations Reshaping the Blood Collection Tube Sector in Response to Emerging Healthcare Demands
Technological advancements are propelling the blood collection tube sector into a new era of performance and safety. Automated cap pierce systems, novel clot activators, and specialized separator gels have accelerated sample processing while reducing pre-analytical errors. At the same time, a growing emphasis on point-of-care testing has driven demand for tubes compatible with portable analyzers and rapid turnaround workflows.
Moreover, material science innovations have introduced lightweight plastic tubes with enhanced rigidity and glass tubes with improved break resistance. These shifts reflect industry efforts to reconcile concerns around environmental impact, supply chain stability, and user ergonomics. Collectively, such innovations are reshaping procurement criteria, prompting laboratories and hospitals to seek solutions that balance cost, performance, and sustainability.
Assessing the Far-Reaching Consequences of Recent United States Tariff Measures on Blood Collection Tube Import Dynamics and Supply Chain Resilience
The introduction of new tariff measures by the United States has led to a reexamination of import dependencies for blood collection tubes. Suppliers that historically relied on cross-border sourcing are now grappling with increased landed costs and extended lead times. As a result, managers are assessing the feasibility of nearshoring production or securing long-term contracts to hedge against further tariff escalations.
Consequently, strategic buyers are prioritizing supply chain resilience by diversifying their vendor base and negotiating more flexible terms. In certain cases, organizations are collaborating with domestic manufacturers to tailor product specifications and qualify secondary packaging. Looking ahead, maintaining a balanced procurement strategy that aligns cost control with uninterrupted availability will remain paramount in mitigating the ongoing impacts of tariff-related disruptions.
Delving into the Multifaceted Segmentation of Blood Collection Tubes Across Types, Materials, Applications, and End Users to Reveal Strategic Opportunities
A comprehensive analysis of blood collection tube demand reveals critical distinctions across multiple axes. When examining tube types, it becomes clear that the choice between citrate tubes for coagulation studies and EDTA tubes for hematology assessments influences procurement patterns. Similarly, glucose tubes, heparin tubes, plasma separation tubes, and serum separation tubes each address specific diagnostic requirements, shaping inventory management decisions in clinical settings.
Equally instructive is the comparison of tube materials. Glass tubes continue to be favored for applications demanding superior clarity and chemical resistance, whereas plastic tubes offer enhanced safety and reduced breakage risk. Procurement teams must weigh these trade-offs in light of storage, transportation, and disposal protocols. In parallel, varied applications-from blood banking through clinical diagnostics to forensic analysis, molecular diagnostics, and research and development-drive differentiated volume requirements and tube specifications.
End user profiles further refine market segmentation insights. Blood banks demand high throughput and standardized lot control. Diagnostic laboratories seek compatibility with automated handling systems. Home care settings require easy-to-use formats and leak-proof designs. Hospitals emphasize clinician safety and rapid turnaround, while research institutions prioritize customization and reagent integration. Recognizing the interplay of these segments is essential for aligning product portfolios with emerging customer expectations.
Examining Regional Dynamics and Growth Drivers for Blood Collection Tubes Across Americas, Europe Middle East & Africa, and Asia-Pacific to Guide Strategy
Regional market characteristics underscore the diversity of demand drivers and regulatory landscapes. In the Americas, well-established healthcare infrastructure and strong private-public partnerships foster continuous investments in diagnostic capabilities. Laboratories and hospitals in North and South America often spearhead early adoption of next-generation tube technologies due to competitive pressures and rigorous accreditation requirements.
Meanwhile, Europe, the Middle East & Africa exhibit a mosaic of regulatory frameworks and economic conditions. The European Union’s in vitro diagnostic regulations harmonize product approvals across member states, creating a unified standard for tube performance. In contrast, markets in the Middle East and Africa are catalyzing growth through public health initiatives and modernization of laboratory networks.
In Asia-Pacific, rapid urbanization, expanding healthcare coverage, and rising disposable incomes are fueling elevated testing volumes. Emerging economies are investing in domestic manufacturing capabilities to reduce import reliance. Across all regions, supply chain optimization and localized production remain critical strategies to ensure consistent access to high-quality blood collection tubes.
Highlighting Competitive Profiles and Strategic Initiatives of Leading Blood Collection Tube Manufacturers to Illustrate Market Leadership and Innovation Trends
Leading manufacturers have adopted distinct strategies to solidify their positions in the blood collection tube sector. Some have prioritized product diversification, unveiling proprietary additive formulations that enhance sample stability and broadening their portfolios to cover clinical, molecular, and forensic applications. Others have pursued targeted partnerships with diagnostic instrument providers, ensuring seamless integration and co-branding opportunities.
In addition, vertical integration has emerged as a key competitive lever. By controlling raw material sourcing or investing in automated filling and labeling lines, certain firms have achieved cost efficiencies and accelerated time to market. Geographic expansion remains a focal point, with several companies establishing distribution centers in high-growth regions to reduce lead times and adapt to local regulatory requirements.
Collectively, these strategic initiatives illustrate how market leaders are balancing innovation, operational excellence, and customer engagement to meet evolving clinical demands while reinforcing their global footprint.
Offering Clear Recommendations for Industry Leaders to Navigate Regulatory, Technological, and Supply Chain Challenges in Blood Collection
To navigate the complexities of this evolving landscape, industry leaders should first invest in research and development that anticipates emerging diagnostic modalities. By collaborating with clinical partners to validate novel tube chemistries and coatings, organizations can position themselves at the forefront of precision medicine workflows.
Furthermore, leaders must enhance supply chain agility by diversifying manufacturing footprints and cultivating relationships with multiple raw material suppliers. This approach not only buffers against tariff-driven cost volatility but also supports regional compliance and rapid delivery to end users. In addition, embedding digital tracking solutions-from barcode serialization to cold-chain monitoring sensors-will bolster chain-of-custody assurances and strengthen regulatory alignment.
Finally, forging strategic alliances with diagnostic instrument manufacturers, healthcare providers, and regulatory consultants can expedite product approvals and drive cross-functional innovation. By adopting these proactive measures, companies will be well-equipped to capitalize on new market opportunities and sustain competitive advantage.
Detailing the Rigorous Research Methodology Used to Explore Blood Collection Tube Market Dynamics Through Data Collection, Validation, and Analytical Techniques
The analysis underpinning this report combined rigorous primary and secondary research methodologies. First, interviews were conducted with laboratory directors, procurement specialists, and product development executives to capture firsthand perspectives on operational challenges and unmet needs. These qualitative insights were triangulated with data drawn from regulatory filings, industry white papers, and internal company disclosures.
Subsequently, a structured validation process was implemented. Cross-referencing supplier catalogs and certification records ensured the accuracy of technical specifications and compliance statuses. Analytical frameworks, including SWOT analysis and value chain mapping, provided a systematic basis for evaluating competitive positioning and innovation trajectories. Finally, scenario modeling was employed to assess the potential impacts of tariff changes and regional policy shifts, yielding a robust foundation for strategic recommendations.
Synthesizing Key Insights and Considerations to Provide a Concluding Perspective on the Future Trajectory of Blood Collection Tubes in Healthcare
Throughout this executive summary, key themes have emerged: the critical role of material innovations, the impact of geopolitical factors on supply chain resilience, and the value of segmentation insights across types, applications, and end users. Regional analyses further highlighted the necessity of aligning manufacturing footprints with local regulatory environments and healthcare infrastructure.
By synthesizing the competitive moves of leading manufacturers and outlining actionable recommendations for research investment, supply chain diversification, and digital traceability, this report offers a comprehensive perspective on the forces shaping the blood collection tube sector. As diagnostic workflows evolve and patient-centric care continues to expand, stakeholders must remain vigilant and adaptive to sustain growth and ensure clinical excellence. These insights will serve as a roadmap for organizations seeking to strengthen their market position and deliver reliable, innovative solutions.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
Tube Type
Citrate Tubes
EDTA Tubes
Glucose Tubes
Heparin Tubes
Plasma Separation Tubes (PST)
Serum Separation Tubes (SST)
Material
Glass Tubes
Plastic Tubes
Application
Blood Banking
Clinical Diagnostics
Forensic
Molecular Diagnostics
Research & Development
End User
Blood Banks
Diagnostic Laboratories
Home Care Settings
Hospitals
Research Institutions
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
Americas
North America
United States
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Colombia
Peru
Europe, Middle East & Africa
Europe
United Kingdom
Germany
France
Russia
Italy
Spain
Netherlands
Sweden
Poland
Switzerland
Middle East
United Arab Emirates
Saudi Arabia
Qatar
Turkey
Israel
Africa
South Africa
Nigeria
Egypt
Kenya
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
Thailand
Malaysia
Singapore
Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
Abbott Laboratories
AdvaCare Pharma
Becton, Dickinson & Company
Biosigma S.p.A.
Bio‐Rad Laboratories, Inc.
Cardinal Health, Inc.
CML BIOTECH LIMITED
Convergent Technologies GmbH
Corning Incorporated
FL Medical S.R.L.
Greiner Bio One International Gmbh
Haemonetics Corporation
Labtech S.r.l.
Medline Industries, Inc.
Medtronic plc
Merck KGaA.
Micsafe Medical Group
Nanjing Vazyme Medical Technology Co., Ltd.
Nipro Medical Corporation
QIAGEN N.V.
Radiometer Medical ApS
SARSTEDT AG & Co. KG
Simport, Inc.
Terumo Corporation
Thermo Fisher Scientific
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
185 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Integration of digital barcoding and RFID tracking for specimen traceability in clinical labs
- 5.2. Development of novel polymer-coated tubes to enhance analyte stability during transport and storage
- 5.3. Surge in demand for low-volume micro-collection tubes driven by point-of-care testing applications
- 5.4. Adoption of ecofriendly and biodegradable tube materials to reduce laboratory plastic waste footprint
- 5.5. Expansion of specialized tubes for cell-free DNA and circulating tumor cell analysis in oncology diagnostics
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Blood Collection Tubes Market, by Tube Type
- 8.1. Citrate Tubes
- 8.2. EDTA Tubes
- 8.3. Glucose Tubes
- 8.4. Heparin Tubes
- 8.5. Plasma Separation Tubes (PST)
- 8.6. Serum Separation Tubes (SST)
- 9. Blood Collection Tubes Market, by Material
- 9.1. Glass Tubes
- 9.2. Plastic Tubes
- 10. Blood Collection Tubes Market, by Application
- 10.1. Blood Banking
- 10.2. Clinical Diagnostics
- 10.3. Forensic
- 10.4. Molecular Diagnostics
- 10.5. Research & Development
- 11. Blood Collection Tubes Market, by End User
- 11.1. Blood Banks
- 11.2. Diagnostic Laboratories
- 11.3. Home Care Settings
- 11.4. Hospitals
- 11.5. Research Institutions
- 12. Blood Collection Tubes Market, by Region
- 12.1. Americas
- 12.1.1. North America
- 12.1.2. Latin America
- 12.2. Europe, Middle East & Africa
- 12.2.1. Europe
- 12.2.2. Middle East
- 12.2.3. Africa
- 12.3. Asia-Pacific
- 13. Blood Collection Tubes Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
- 14. Blood Collection Tubes Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
- 15. Competitive Landscape
- 15.1. Market Share Analysis, 2024
- 15.2. FPNV Positioning Matrix, 2024
- 15.3. Competitive Analysis
- 15.3.1. Abbott Laboratories
- 15.3.2. AdvaCare Pharma
- 15.3.3. Becton, Dickinson & Company
- 15.3.4. Biosigma S.p.A.
- 15.3.5. Bio‐Rad Laboratories, Inc.
- 15.3.6. Cardinal Health, Inc.
- 15.3.7. CML BIOTECH LIMITED
- 15.3.8. Convergent Technologies GmbH
- 15.3.9. Corning Incorporated
- 15.3.10. FL Medical S.R.L.
- 15.3.11. Greiner Bio One International Gmbh
- 15.3.12. Haemonetics Corporation
- 15.3.13. Labtech S.r.l.
- 15.3.14. Medline Industries, Inc.
- 15.3.15. Medtronic plc
- 15.3.16. Merck KGaA.
- 15.3.17. Micsafe Medical Group
- 15.3.18. Nanjing Vazyme Medical Technology Co., Ltd.
- 15.3.19. Nipro Medical Corporation
- 15.3.20. QIAGEN N.V.
- 15.3.21. Radiometer Medical ApS
- 15.3.22. SARSTEDT AG & Co. KG
- 15.3.23. Simport, Inc.
- 15.3.24. Terumo Corporation
- 15.3.25. Thermo Fisher Scientific
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
